Control of RUNX2 isoform expression: the role of promoters and enhancers
about
Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNARetinoblastoma binding protein-1 (RBP1) is a Runx2 coactivator and promotes osteoblastic differentiation.Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse modelRunx2-I isoform contributes to fetal bone formation even in the absence of specific N-terminal amino acids.Assessment of transmission distortion on chromosome 6p in healthy individuals using tagSNPs.The Role of RUNX2 in Osteosarcoma Oncogenesis.The transcription factor Runx2 is under circadian control in the suprachiasmatic nucleus and functions in the control of rhythmic behaviorRunx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.Dose-dependent effects of Runx2 on bone development.Post-translational Regulation of Runx2 in Bone and Cartilage.Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid CancerThymosin beta 4 is associated with RUNX2 expression through the Smad and Akt signaling pathways in mouse dental epithelial cells.Effects of Cissus quadrangularis on the proliferation, differentiation and matrix mineralization of human osteoblast like SaOS-2 cells.Transcriptome analysis of periodontitis-associated fibroblasts by CAGE sequencing identified DLX5 and RUNX2 long variant as novel regulators involved in periodontitis.DNA methylation of the RUNX2 P1 promoter mediates MMP13 transcription in chondrocytes.Family-based association study of polymorphisms in the RUNX2 locus with hand bone length and hand BMD.De novo three-way chromosome translocation 46,XY,t(4;6;21)(p16;p21.1;q21) in a male with cleidocranial dysplasia.Identification of a novel, methylation-dependent, RUNX2 regulatory region associated with osteoarthritis riskMitigative effect of erythromycin on PMMA challenged preosteoblastic MC3T3-E1 cells
P2860
Q24641909-7AB99C86-5DC7-4712-9958-442080BFF66FQ30983671-722802EC-66E1-4578-923C-C72BE3803AD1Q33798299-980BB27E-9AA2-4643-BF02-61288F570FBBQ34227055-26AD1478-8448-464C-8DA6-36D81D569EB8Q34327057-F6FD3CF2-988A-4486-A538-2E0ED1DDC914Q34423871-7245958B-26AC-456C-BFEC-E229F13314CEQ34571113-4D7DA26E-A42A-4ECA-9044-99C4F4A25770Q37151181-5743E084-9FDC-445A-B538-EE062344CD06Q37396635-E0EFD42C-0AAA-4B33-B4CB-98E486C3713DQ37592911-4B5C06CB-6E9E-4617-B41B-ED18F024088AQ38766996-2A1B1100-297C-4704-9CB8-26C2461E2FD1Q38903594-E5B838D1-BBC7-4552-9E58-4FD4D4B93193Q39594962-5BF5F497-1152-4456-9E5C-9DB231CA6958Q41128772-00949634-16F5-4DC5-9310-D1890AFDE9BEQ41352907-148B9768-2F41-49F8-AA36-35AD713D96EAQ47699681-E6C2FF7A-D2CF-4653-BE5D-F5F7FCDABB24Q51966876-77C14DED-984C-4F46-A4B8-ACDF08DFFFE7Q58788904-A78BD180-8E8C-4C8B-90FD-B87853BED005Q59074642-270953C3-81BB-4EF1-A829-4F0342E6FA1D
P2860
Control of RUNX2 isoform expression: the role of promoters and enhancers
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Control of RUNX2 isoform expression: the role of promoters and enhancers
@ast
Control of RUNX2 isoform expression: the role of promoters and enhancers
@en
Control of RUNX2 isoform expression: the role of promoters and enhancers
@nl
type
label
Control of RUNX2 isoform expression: the role of promoters and enhancers
@ast
Control of RUNX2 isoform expression: the role of promoters and enhancers
@en
Control of RUNX2 isoform expression: the role of promoters and enhancers
@nl
prefLabel
Control of RUNX2 isoform expression: the role of promoters and enhancers
@ast
Control of RUNX2 isoform expression: the role of promoters and enhancers
@en
Control of RUNX2 isoform expression: the role of promoters and enhancers
@nl
P2860
P3181
P356
P1476
Control of RUNX2 isoform expression: the role of promoters and enhancers
@en
P2093
Florian Otto
P2860
P304
P3181
P356
10.1002/JCB.20471
P407
P577
2005-06-01T00:00:00Z